# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000939767-17-000059
Filing Date
2017-04-13
Accepted
2017-04-13 07:52:33
Documents
7
Period of Report
2017-05-24
Effectiveness Date
2017-04-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def14a-20170413xproxy.htm | DEF 14A | 1489827
2 |  | a02klpbexelixiscommon032001.jpg | GRAPHIC | 228709
3 |  | a02klpbexelixiscommon032002.jpg | GRAPHIC | 130511
4 |  | allotherneoscharta03.jpg | GRAPHIC | 27484
5 |  | ceocharta03.jpg | GRAPHIC | 26802
6 |  | exelixis1a02.jpg | GRAPHIC | 8125
7 |  | exelsiggca02.jpg | GRAPHIC | 40817
| Complete submission text file | 0000939767-17-000059.txt |  | 2128643

Mailing Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 210 E. GRAND AVE SOUTH SAN FRANCISCO CA 94080 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
Type: DEF 14A | Act: 34 | File No.: 000-30235 | Film No.: 17759338
SIC: 8731 Services-Commercial Physical & Biological Research